Meanwhile, current serum diagnostic biomarkers for GC, including carbohydrate antigen 724 (CA-724) and carcinoembryonic antigen (CEA) have shown low specificity and sensitivity for LNM prediction. This evidence concerns the gene CEACAM5 and gastric cancer.